The Enigma of Testing

Young African American doctor in uniform measuring blood pressure of patient

With every proposed test there must be an evaluation of the potential benefit, but also the risk: every test has risks.

Today’s topic was inspired by a recent discussion on social media, where a well-known compliance expert, who also happened to previously work for the government, posted about a cardiac test he had that was denied by his insurance company.

The story he related is that his father had heart disease, with two heart attacks and stents, but is still alive and well at 80 – and as a result, he gets a yearly EKG at his yearly physical. One year the EKG showed an abnormality, so a nuclear stress test was ordered.

The test was thankfully normal. He also has “borderline high cholesterol.” He saw a new cardiologist this year, who looked at all the tests and recommended he get a coronary artery calcium scan. He got the test, and again, thankfully, it showed no calcium buildup in his coronary arteries. And then his insurance company denied the claim for the test.

I commented that no insurer will pay for this test, because it is not accepted as a valid screening test for coronary artery disease, even though it is a Food and Drug Administration (FDA)-approved test. In fact, most hospitals gave up submitting insurance claims years ago, and simply do the test for $50-$100 in cash. This gentleman was insistent that it should be covered, and will continue to fight the denial.

Now, granted, I do not have all the details, such as his actual lipid profile breakdown, nor his blood pressure, but let’s look closer. It is important to remember that for every test we do, we must evaluate not only the potential benefit of the test, but also the risk. That’s right: every test has risks.

One can argue that there is no risk in getting an EKG (except the pain of pulling off those little stickers). But as we saw with this patient, that yearly, nearly risk-free EKG led to a costly nuclear stress test, which involved exposure to radiation, which fortunately yielded a normal result. But what if it was abnormal, and he had an angiogram, and his arteries all looked normal, but they dissected an artery and found he needed a stent?

These risks are real. When Gilda Radner died of ovarian cancer, her husband, Gene Wilder, advocated for universal screening. But the scientists looked at the data and realized that more patients would be harmed by the cascade of tests that would result from a positive screening test than lives saved detecting cancer early, because the test is not perfect. Imagine undergoing a laparoscopy, having your bowel perforated, requiring a colostomy, and then being told that the good news was that there was no ovarian cancer?

Then there is the issue of what will be done with the results. What would the cardiologist recommend if the test was abnormal, compared to what they would recommend without having that result? In the case of a coronary artery calcium test, the significant issue at hand is the use of a cholesterol-lowering medication. Since this person may a significant family history (we don’t know at what age the father developed heart disease) and seemingly has elevated cholesterol (with no mention of LDL or HDL levels, an important factor), they might be considered at intermediate risk of developing coronary artery disease. As a result, a positive test may be viewed as another risk factor in the development of symptomatic heart disease, and the doctor may recommend a statin.

On the other hand, the patient is seemingly already at risk, and perhaps should be taking a statin regardless of the test result, in which case the test provides no additional information. And since this heart scan also has views of the other components of the thorax, there is the possibility of an incidental finding, perhaps a small lung nodule, which would then lead down the cascade of tests needed to evaluate that, along with the risks therein.

You probably have the vague sense from past articles that I am no fan of insurance companies, but in this case, I am on their side. They have done the analysis and have determined that it does not meet their coverage criteria. Just because a doctor and a patient want a test does not necessarily mean it should be covered. The science must support its use. And right now, the science is not there.

Remember, if you are going to do a test on a patient who feels perfectly fine, you better be sure you aren’t going to make things worse.

Programming Note: Listen every Monday when Dr. Ronald Hirsch makes his Monday rounds on Monitor Mondays, 10 Eastern, sponsored by R1 RCM.

Facebook
Twitter
LinkedIn

Ronald Hirsch, MD, FACP, ACPA-C, CHCQM, CHRI

Ronald Hirsch, MD, is vice president of the Regulations and Education Group at R1 Physician Advisory Services. Dr. Hirsch’s career in medicine includes many clinical leadership roles at healthcare organizations ranging from acute-care hospitals and home health agencies to long-term care facilities and group medical practices. In addition to serving as a medical director of case management and medical necessity reviewer throughout his career, Dr. Hirsch has delivered numerous peer lectures on case management best practices and is a published author on the topic. He is a member of the Advisory Board of the American College of Physician Advisors, and the National Association of Healthcare Revenue Integrity, a member of the American Case Management Association, and a Fellow of the American College of Physicians. Dr. Hirsch is a member of the RACmonitor editorial board and is regular panelist on Monitor Mondays. The opinions expressed are those of the author and do not necessarily reflect the views, policies, or opinions of R1 RCM, Inc. or R1 Physician Advisory Services (R1 PAS).

Related Stories

New Online Drug Lookup Tool Unveiled

New Online Drug Lookup Tool Unveiled

MedLearn Media is launching an online resource believed to be useful for professional coders, charge capture, compliance, and revenue integrity specialists alike. DrugCode Pro is

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

Stop revenue leakage and boost hospital performance by mastering risk adjustment and HCCs. This essential webcast with expert Cheryl Ericson, RN, MS, CCDS, CDIP, will reveal how inaccurate patient acuity documentation leads to lost reimbursements through penalties from poor quality scores. Learn the critical differences between HCCs and traditional CCs/MCCs, adapt your CDI workflows, and ensure accurate payments in Medicare Advantage and value-based care models. Perfect for HIM leaders, coders, and CDI professionals.  Don’t miss this chance to protect your hospital’s revenue and reputation!

May 29, 2025
I050825

Mastering ICD-10-CM Coding for Diabetes and it’s Complications: Avoiding Denials & Ensuring Compliance

Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!

May 8, 2025

Trending News

Featured Webcasts

Navigating the 3-Day & 1-Day Payment Window: Compliance, Billing, and Revenue Protection

Navigating the 3-Day & 1-Day Payment Window: Compliance, Billing, and Revenue Protection

Struggling with CMS’s 3-Day Payment Window? Join compliance expert Michael G. Calahan, PA, MBA, CCO, to master billing restrictions for pre-admission and inter-facility services. Learn how to avoid audit risks, optimize revenue cycle workflows, and ensure compliance across departments. Critical for C-suite leaders, providers, coders, revenue cycle teams, and compliance teams—this webcast delivers actionable strategies to protect reimbursements and meet federal regulations.

May 15, 2025
Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Providers face increasing Medicare audits when using skin substitute grafts, leaving many unprepared for claim denials and financial liabilities. Join veteran healthcare attorney Andrew B. Wachler, Esq., in this essential webcast and master the Medicare audit process, learn best practices for compliant billing and documentation, and mitigate fraud and abuse risks. With actionable insights and a live Q&A session, you’ll gain the tools to defend your practice and ensure compliance in this rapidly evolving landscape.

April 17, 2025
Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Dr. Ronald Hirsch dives into the basics of Medicare for clinicians to be successful as utilization review professionals. He’ll break down what Medicare does and doesn’t pay for, what services it provides and how hospitals get paid for providing those services – including both inpatient and outpatient. Learn how claims are prepared and how much patients must pay for their care. By attending our webcast, you will gain a new understanding of these issues and be better equipped to talk to patients, to their medical staff, and to their administrative team.

March 20, 2025

Rethinking Observation Metrics: Standardizing Data for Better Outcomes

Hospitals face growing challenges in measuring observation metrics due to inconsistencies in classification, payer policies, and benchmarking practices. Join Tiffany Ferguson, LMSW, CMAC, ACM, and Anuja Mohla, DO, FACP, MBA, ACPA-C, CHCQM-PHYADV as they provide critical insights into refining observation metrics. This webcast will address key issues affecting observation data integrity and offer strategies for improving consistency in reporting. You will learn how to define meaningful metrics, clarify commonly misinterpreted terms, and apply best practices for benchmarking, and gain actionable strategies to enhance observation data reliability, mitigate financial risk, and drive better decision-making.

February 25, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24